ATE326950T1 - Verfahren zur herstellung von zusammensetzungen mit beschleunigter abgabe unter verwendung von komprimierten fluiden - Google Patents

Verfahren zur herstellung von zusammensetzungen mit beschleunigter abgabe unter verwendung von komprimierten fluiden

Info

Publication number
ATE326950T1
ATE326950T1 AT01911742T AT01911742T ATE326950T1 AT E326950 T1 ATE326950 T1 AT E326950T1 AT 01911742 T AT01911742 T AT 01911742T AT 01911742 T AT01911742 T AT 01911742T AT E326950 T1 ATE326950 T1 AT E326950T1
Authority
AT
Austria
Prior art keywords
active ingredient
accelerated release
compressed fluid
preparing
release compositions
Prior art date
Application number
AT01911742T
Other languages
English (en)
Inventor
Italo Colombo
Paolo Pallado
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Application granted granted Critical
Publication of ATE326950T1 publication Critical patent/ATE326950T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01911742T 2000-03-17 2001-03-07 Verfahren zur herstellung von zusammensetzungen mit beschleunigter abgabe unter verwendung von komprimierten fluiden ATE326950T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000560A IT1318404B1 (it) 2000-03-17 2000-03-17 Processo per la preparazione di formulazioni a rilascio accelerato conimpiego di fluidi compressi.

Publications (1)

Publication Number Publication Date
ATE326950T1 true ATE326950T1 (de) 2006-06-15

Family

ID=11444510

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01911742T ATE326950T1 (de) 2000-03-17 2001-03-07 Verfahren zur herstellung von zusammensetzungen mit beschleunigter abgabe unter verwendung von komprimierten fluiden

Country Status (13)

Country Link
US (1) US6913779B2 (de)
EP (1) EP1267836B1 (de)
JP (1) JP2003526653A (de)
KR (1) KR20030070815A (de)
CN (1) CN1418090A (de)
AT (1) ATE326950T1 (de)
AU (1) AU4068201A (de)
BR (1) BR0109312A (de)
CA (1) CA2403343C (de)
DE (1) DE60119914D1 (de)
IT (1) IT1318404B1 (de)
MX (1) MXPA02009056A (de)
WO (1) WO2001068054A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE416784T1 (de) * 2000-12-01 2008-12-15 Takeda Pharmaceutical Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz
GB0126716D0 (en) * 2001-11-07 2002-01-02 Advanced Phytonics Ltd Method for the production of particles
WO2003074028A1 (en) * 2002-03-07 2003-09-12 Eurand Pharmaceuticals Ltd. Process for loading and thermodynamically activating drugs on polymers by means of supercritical fluids
GB0205868D0 (en) * 2002-03-13 2002-04-24 Univ Nottingham Polymer composite with internally distributed deposition matter
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
BRPI0720550A2 (pt) * 2006-10-06 2014-07-08 Newsouth Innovations Pty Ltd Formação de partículas
GB0812742D0 (en) * 2008-07-11 2008-08-20 Critical Pharmaceuticals Ltd Process
FR2945449B1 (fr) * 2009-05-15 2012-10-05 Pf Medicament Procede d'impregnation par co2 supercritique
CA2765033C (en) 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CN105687141A (zh) * 2016-03-04 2016-06-22 中国药科大学 超临界抗溶剂法制备尼美舒利-左旋聚乳酸(Nim-PLLA)复合微球的工艺研究
CN110859807A (zh) * 2018-08-28 2020-03-06 康芝药业股份有限公司 一种尼美舒利的固体分散微粉及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225192A (en) * 1988-10-17 1993-07-06 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
IT1230566B (it) * 1988-10-17 1991-10-28 Vectorpharma Int Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione
CA2017332A1 (en) * 1989-06-29 1990-12-29 Richard W. Greiner Pharmaceutically impregnated catheters
US5340614A (en) * 1993-02-11 1994-08-23 Minnesota Mining And Manufacturing Company Methods of polymer impregnation
WO1996029998A1 (en) * 1995-03-28 1996-10-03 Fidia Advanced Biopolymers S.R.L. Nanospheres comprising a biocompatible polysaccharide
IT1296464B1 (it) * 1997-11-19 1999-06-25 Vectorpharma Int Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
WO2001087368A1 (en) * 2000-05-16 2001-11-22 Ortho-Mcneil Pharmaceutical, Inc. Process for coating medical devices using super-critical carbon dioxide

Also Published As

Publication number Publication date
WO2001068054A1 (en) 2001-09-20
CA2403343A1 (en) 2001-09-20
CN1418090A (zh) 2003-05-14
CA2403343C (en) 2010-05-11
US20030161957A1 (en) 2003-08-28
DE60119914D1 (de) 2006-06-29
ITMI20000560A1 (it) 2001-09-17
BR0109312A (pt) 2002-12-17
IT1318404B1 (it) 2003-08-25
US6913779B2 (en) 2005-07-05
AU4068201A (en) 2001-09-24
EP1267836A1 (de) 2003-01-02
MXPA02009056A (es) 2004-09-06
JP2003526653A (ja) 2003-09-09
EP1267836B1 (de) 2006-05-24
ITMI20000560A0 (it) 2000-03-17
KR20030070815A (ko) 2003-09-02

Similar Documents

Publication Publication Date Title
ATE240718T1 (de) Verfahren zur herstellung von arzneiformen mit kontrollierter wirkstoffabgabe auf polymerbasis
ATE171965T1 (de) Verfahren zur herstellung niedrigviskoser, wasserlöslicher polymerdispersionen
ATE221373T1 (de) Verfahren zur herstellung von präparaten mit kontrollierter wirkstofffreisetzung auf basis von polymeren
ATE326950T1 (de) Verfahren zur herstellung von zusammensetzungen mit beschleunigter abgabe unter verwendung von komprimierten fluiden
DE60012981D1 (de) Verfahren zur herstellung von polymeren durch eine kontrollierte radikalischpolymerisation mit xanthaten
DE69739843D1 (de) Verfahren zur herstellung einer verbindung durch polymerisierung einer modelldroge
ATE177449T1 (de) Verfahren zur herstellung von wasserlöslichen polymerdispersionen mit hohem polymeranteil
NO965403L (no) Mikropartikler for frigjöring av aktive preparat
ATE233088T1 (de) Verfahren zur herstellung einer zusammensetzung mit verzoegerter abgabe
ATE245022T1 (de) Verfahren zur herstellung von mikropartikeln
ATE258685T1 (de) Makromolekulare mikropartikel und verfahren zur ihrer herstellung
DE60235268D1 (de) Anionische Copolymere erhältlich in inverser Emulsion sowie deren Verwendung zur Herstellung von Cellulosefaser-Mischungen
DE60136958D1 (de) Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz
ATE385430T1 (de) Verwendung eines haarbehandlungsmittel mit gehalt an einer polymerkombination
ATE320451T1 (de) Verfahren zur herstellung von blockcopolymeren durch eine kontrollierte radikalpolymerisation in gegenwart von einer disulfidverbindung
DE60033436D1 (de) Verfahren zur herstellung von vergrösserten latexteilchen
WO1998050082A3 (en) Tissue fixation with cross-linking compounds
DE60111412D1 (de) Verfahren zur herstellung einer emulsion, deren organische phase eine hohe viskosität hat
TW200613385A (en) Improved method of manufacturing superabsorbent polymers
DE502005008386D1 (de) Verfahren zur herstellung von polymeren durch sprühpolymerisation
DE50108707D1 (de) Verfahren zur herstellung kautschukhaltiger thermoplastischer formmassen
BR0111522A (pt) Cabo ou componente de cabo, ou método de revestimento de um cabo ou componente de cabo
ATE260303T1 (de) Verfahren zur herstellung eines polymeren netzwerkes
DE60113956T2 (de) Verfahren zur Herstellung eines epoxydierten Polymers
ATA413979A (de) Verfahren zur herstellung von wasserloeslichen, insbesondere als flockungsmittel verwendbaren organischen polymeren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties